Meningitis B* was the leading cause of IMD in Canada from 2011 through 2015.

Meningitis B* can cause life-threatening infections

Up to 1 in 10 patients die (typically within 24 to 48 hours after the onset of symptoms)§

Of those who recover, up to 1 in 3 patients experience serious complications, hearing loss, neurologic disabilities and amputations§

In Canada, vaccination against meningitis B* is not part of the routine childhood vaccination schedule that your child receives. Ask your doctor about vaccinating your child against meningitis B.*

Prevention is the best strategy to help protect against meningitis B.*

Help protect your child against meningococcal disease caused by meningitis B.*

Talk to your doctor about vaccinating your child with BEXSERO or locate the nearest clinic in your community by using the clinic finder below.

BEXSERO is a vaccine, for individuals from 2 months through 25 years of age, for the prevention of meningococcal disease caused by the Neisseria meningitidis group B bacteria.

* Meningococcal disease caused by Neisseria meningitidis group B strains.

† BEXSERO is not expected to provide protection against all circulating meningococcal serogroup B strains and does not offer protection against strains A, C, Y, and W-135.

‡ Based on most recent data available.

§ BEXSERO does not treat or reduce the consequences of meningococcal meningitis, including meningitis, sepsis, and death.